Masterclass: ACCELERATE Overview
ANDHealth’s Masterclass: ACCELERATE Program is the only intensive accelerator program designed specifically for companies seeking to commercialise evidence-based digital health products. It is globally unique and engages with international industry leaders in a private, participant only forum.

The interactive program features:
• Workshop-style learning groups
• Real-world case studies
• Advanced business concepts and strategies
• Expert guest speakers
• Networking opportunities
The Masterclass features more than 50 expert speakers drawn from industry with proven backgrounds, who can provide you with commercialisation-focused real-world advice, quality feedback, and actionable answers, and the ability to ask questions specific to your company. Previous speakers have included CEO’s of the world’s most successful digital therapeutics companies, large US Payers, US corporate and institutional investors, Australian venture capital directors, leading lawyers, governance experts and proven entrepreneurs and advisors.
The Participants
Masterclass spaces are limited. Our intensive workshop style and industry-led delivery means that we can only accept 30 registrations per intake. We welcome applications from across Australia, from digital health entrepreneurs, industry professionals, service providers, clinicians, investors and companies. If you are actively involved in digital health commercialisation in any way, please do apply.
ANDHealth+ Access
Masterclass is the best possible preparation you can take if you plan to apply for our flagship ANDHealth+ program. ANDHealth+ cohort companies have achieved significant outcomes. If you would like to join them in ANDHealth+ 2021, please be aware that applications are highly competitive and preference will be given to companies that have completed programs that enabled them to address common pitfalls, unique challenges and knowledge gaps in commercialising digital health.
The Masterclass Curriculum
Masterclass spaces are limited. Our intensive workshop style and industry-led delivery means that we can only accept a limited number of registrations. Applications are welcomed from digital health entrepreneurs, industry professionals, technology transfer executives, service providers, clinicians and investors across Australia. If you are actively involved in digital health commercialisation in any way, please apply.

The masterclass is designed for digital health companies which:

• Have achieved proof of principle and are evidence-based with a clear focus on changing outcomes for patients;
• Have some voice of user and/or customer feedback;
• Are looking to strengthen their clinical and commercial business case; and
• Meet the FDA definition of digital health

For other applicants, you are an:
• An investor, advisor or technology transfer/commercialisation professional in the digital health sector, or;
• An industry professional, consultant, or service provider that actively works with digital health companies, or;
• An academic or policy leader in digital health/health tech/health innovation.
When can I expect to hear an outcome on my application for the program?
Applications stay open for 6 weeks in which we review and accept the applications on a rolling basis in correlation with our partners.
Can I apply from all over Australia?
We welcome applications from across Australia. If you are actively involved in digital health commercialisation in any way, please do apply.
Will I receive feedback about our application if I am unsuccessful?
Yes. We make every effort to provide each unsuccessful applicant with feedback about their application. Feedback may come in the form of a follow-up phone call or email.
Program prices depend on the level of engagement and support from selected Program Partners and will be made available when registrations open.
Successful applicants will be selected based on their suitability for the program and to ensure participants benefit from robust dialogue in a multidisciplinary group.

Registrations for Masterclass are now open. If you’d like to chat to an expert member of the ANDHealth team about your idea, technology or company please contact ANDHealth to arrange and Office Hours consultation.
Digital health companies require specialist support to commercialise. The type of support ANDHealth provides is vital to the early stages of digital health companies to allow them to accelerate their growth. Personify Care is growing rapidly, headquartered in SA, exporting internationally, currently hiring 3 new full-time roles and will expand our team further this financial year; we need to support emerging digital health companies to expand this sector and create digital health jobs from companies headquartered in SA.
Ken Saman
CEO Personify Care
Digital health is an emerging and exponentially growing sector of the health ecosystem. As such, clinicians and entrepreneurs require specialised support to navigate uncharted waters of regulation and evidence-based medicine. It is essential to the growth of the digital health sector in South Australia that we provide this specific support to digital health companies here. I have observed ANDHealth's operations in other states over the last few years and applaud their commitment and the quality of the expertise that they put around the digital health companies that they support. This is resulting in not only health innovation but strong commercial outcomes from the companies they have supported.
Peter Bradley
VP Global Business Development, LBT Innovations
I am very supportive of the work ANDHealth is doing which is unique in the health sector in Australia. Their programs provide invaluable support and advice to people looking to develop, invest and grow in the healthcare IT industry through offering access to business and commercialisation support, deep knowledge of the sector and much needed support to new entrants. I would have welcomed access to these skills as we developed from early stage to full commercialisation.
Kate Quirke
Chief Executive Officer and Managing Director, Alcidion Group Limited (ASX:ALC)
From my perspective as an Advisor to numerous Digital Health organizations, ANDHealth really stands out as a visionary organization with unique leadership that understands the need to target real problems in healthcare and address them with innovation and transformation that are grounded in economic sustainability and successful long-term outcomes.
Aenor J. Sawyer, MD
Chief Medical Officer, NASA, Translational Research Institute for Space Health
“ANDHealth is a key regional organisation for digital health companies in the Australiasia region. Through our involvement with ANDHealth we have made key a range of key international and local connections. We have networked with, shared, and learnt from the ANDHealth community in a collaborative and progressive environment.”
Garth Sutherland
Founder, Adherium Limited
In a relatively short period of time, ANDHealth has made a positive impact and delivered measurable benefits to the digital health and broader biotechnology sectors.
Dr Chris Nave
Managing Director, Brandon Capital Partners
I think the organisation’s proactive attitude, collaborative nature, strategic connections, and expertise are highly beneficial to the growing digital health community; and am delighted to be able to add my name to the list of those supporting ANDHealth’s activities in the future to build expertise in digital health commercialisation with a view to contributing to the nation’s economic prosperity.
Anton van den Hengel
Director, Australian Institute for Machine Learning, School of Computer Science, University of Adelaide
Australia’s digital health sector will experience significant growth over the coming decades. ANDHealth has played and will continue to play a vital role in the development and growth of this sector in Australia, which will be a significant opportunity for STEM job creation and economic growth in the country. I would love to continue supporting ANDHealth in anyway that I can to promote the sector in Australia.
Jarred Shein
Head of Business Development, Asia Pacific, Qure Ventures
We acknowledge the positive impact that ANDHealth has had on the sector and look favourably on their pursuit of public and private funding to support future operations. I believe ANDHealth has delivered great value to the sector and we believe the dedication solely to digital health and informed by industry leaders with proven backgrounds and the national and international networking opportunities in digital health commercialisation through members, partners and networks are of particularly great value.
Dr Rob Grenfell
Director, CSIRO Health and Biosecurity

Join our
mailing list

Stay up to date on news, programs and events
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.